NCT03072810 is a NA clinical trial of Positive mindfulness program in Pain, Chronic, sponsored by Canterbury Christ Church University.

Who is sponsoring NCT03072810?

NCT03072810 is sponsored by Canterbury Christ Church University.

What drugs are being tested in NCT03072810?

Interventions in NCT03072810: Positive mindfulness program.

What condition does NCT03072810 study?

NCT03072810 studies Pain, Chronic.

Is NCT03072810 still recruiting?

NCT03072810 is currently completed. Last updated 7 December 2018.

Last reviewed 2018-12-07 · How we verify

NCT03072810

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Positive Mindfulness Program and Wellbeing in Chronic Pain

Completed NA Last updated 7 December 2018

What this trial tests

NA trial testing Positive mindfulness program in Pain, Chronic in 73 participants. Completed in 1 November 2018.

Timeline

1 March 2017

Primary endpoint
1 November 2018

1 November 2018

Quick facts

Lead sponsor	Canterbury Christ Church University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	73
Start date	1 March 2017
Primary completion	1 November 2018
Estimated completion	1 November 2018
Sites	3 locations across United Kingdom

Drugs / interventions tested

Positive mindfulness program

Conditions studied

Pain, Chronic — all drugs for Pain, Chronic →

Sponsor

Canterbury Christ Church University

Who can join

18 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to increase the well-being of individuals with chronic pain through a 4-week online positive mindfulness programme. Each module, lasting 4 days, will include a daily meditation and focus on a different aspect of positive psychology. This is a quantitative study. The independent variable is participation in the programme. The dependent variables are: wellbeing, mindfulness, pain severity, pain catastrophising and health quality of life. There will be one experimental group who participate in the programme as soon as they are recruited. There will be one control group who are put on a 'wait-list' to complete the programme after an 8 week wait. Pre and post measures will be taken. Participants are being recruited through NHS clinics in London and Oxford, including the Pain Management Centre at Oxford University Hospitals (Churchill site) and INPUT at St Thomas's Hospital (which are participant identification centres). Participants who hear about the study via other means including online or through word of mouth are also being accepted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

NCT06800209 — Pain Reprocessing Therapy in Post-Operative Knee Pain · Phase 2 · recruiting
NCT06512727 — The PROACTIVE Study for Black Elders · NA · recruiting
NCT06837857 — Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain · Phase 2 · recruiting
NCT06541184 — Ziconotide for Non-cancer Pain by Intrathecal Administration · recruiting
NCT06592053 — Affecting Factors for Chronic Pain After Mastectomy · recruiting

Other Canterbury Christ Church University trials

Trials by the same sponsor.

NCT06402461 — Comparing Random Allocation and Allocation by Preference to Mindfulness Practice · NA · completed
NCT07051005 — Feasibility of a Tailored Online Self-compassion Intervention · NA · recruiting
NCT06821841 — Online Physical Activity Intervention for Peri- and Post-menopausal Working Women · NA · completed
NCT06835777 — Neurophysiological Mechanisms of Placebo and Nocebo Effects in Sports - a Protocol Paper · NA · not yet recruiting
NCT05749029 — An Online, Compassion Intervention for Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM). · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03072810 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Canterbury Christ Church University
Last refreshed: 7 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03072810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing